TEPEZZA (teprotumumab-trbw)
Tepezza is an insulin-like growth factor-1 receptor inhibitor used for the treatment of Thyroid Eye Disease (TED) also known as Graves’ Orbitopathy.
Recommended Dosage: The recommended dose of Tepezza is an intravenous infusion of 10 mg per kg for the initial dose followed by an intravenous infusion of 20 mg per kg every 3 weeks for 7 additional infusions. Do not administer tepezza injection as an intravenous push or bolus. It should not be infused concomitantly with other agents.
Adakveo is a selectin blocker used in adults and pediatric patients aged 16 years and older who have sickle cell disease (SCD) to help scale down how often painful crises happen.
Recommended Dosage: The recommended dosage of Adakveo injection is 5 mg per kg administered by intravenous (IV) infusion over a time span of 30 minutes at Week 0th, week 2nd, and every 4th week thereafter.
In case a dose is skipped or missed, administer this medication as quickly as possible. If it is administered within 14 days after the skipped/missed dose, continue dosing as per the patient’s standard schedule. In case this medication is administered beyond 14 days after the skipped or missed dose, continue dosing every 28 days (4 weeks) thereafter. Adakveo may be given either with or without hydroxyurea.
- Teprotumumab may cause infusion reactions. In patients who experience an infusion reaction, consideration should be given to pre-medicating with an antipyretic, antihistamine, corticosteroid or administering all subsequent infusions at a reduced infusion rate.
- The teprotumumab 500 mg treatment may cause an exacerbation of preexisting inflammatory bowel disease (IBD). Monitor patients with inflammatory bowel disease for flare of disease. In case IBD exacerbation is suspected, dosage can be discontinued.
- Increased blood glucose or Hyperglycemia may occur in patients treated with Teprotumumab. Monitor patients for elevated blood glucose and signs/symptoms of hyperglycemia during therapy with Teprotumumab.
- Patients with pre-existing diabetes should be under appropriate glycemic control prior to receiving treatment tepezza 500 mg injection.
- Mechanisms of action of inhibiting insulin-like growth factor-1 receptor (IGF-1R) suggest that tepezza may cause fetal harm if administered to a pregnant woman. Females should inform their health specialist about a known or suspected pregnancy.
What documents are required to import TEPEZZA to India?
TEPEZZA (teprotumumab-trbw) injection can be imported by patients or government hospitals in the name of the patients only.
The following documentation is required to import the product:
- Valid prescription from a qualified doctor.
- Patients diagnostic reports.
- Patients Identity Proof (issued by the Government of India).
How does the order get confirmed?
The order will be confirmed only after the receipt of:
- Valid prescription of Doctor.
- Import permit, if applicable.
Is TEPEZZA available in India?
TEPEZZA (teprotumumab-trbw injection) is a prescription drug that legally requires a medical prescription to be dispensed.
Urgent Meds helps import medicines on the named patient supply (NPS). Urgent Meds is the facilitator providing input on:
- Availability in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, and Pune, etc.).
- Medicine Price.
- Finding genuine and reliable sources from Canada, Europe, the USA, and Australia.
- Ensuring 100% transparency.
TEPEZZA can be made available to patients, doctors, and hospitals in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, Pune, and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.
Urgent Meds can facilitate the supply of TEPEZZA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirements (if applicable).
Please contact +1-647-818-4196 or visit urgentmeds.in for TEPEZZA price in India.
We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
What is the Generic Name for the trade name drug Tepezza®?
Teprotumumab is the Generic Name for the trade name drug Tepezza®.
What is the Manufacturer Name of Tepezza®?
Tepezza® is manufactured by Horizon Therapeutics.
Is Tepezza® approved by the FDA?
Yes, Tepezza® is approved by the FDA. Date of approval: January 21, 2020.
What is Tepezza®?
Tepezza® (teprotumumab-trbw) reduces eye bulging and double vision. It also enhances the signs and symptoms of Thyroid Eye Disease, including eye pain, redness, and swelling.
What is the dosage and form of Tepezza® supplied?
Tepezza® is supplied as an Injection: 500 mg lyophilized powder in a single-dose vial for reconstitution for intravenous administration.
How much does Teprotumumab cost in India?
The cost of teprotumumab in India is very reasonable. To procure this medication for Thyroid Eye Disease authentically, you can call or WhatsApp +1-647-818-4196 or visit urgentmeds.in.
What are the most common side effects due to Tepezza®?
The most common side effects due to Tepezza® include:
- Dry skin
- Muscle spasm
- Diarrhea
- Nausea
- Alopecia
- Fatigue
- Hyperglycemia
- Dysgeusia
- Hearing impairment
- Headache
What are the storage conditions of Tepezza®?
Refrigerate Tepezza injection 500 mg vial at 2°C to 8°C (36°F to 46°F) in the original carton until the time of use to protect it from light. Do not freeze.
Do you have any other questions or need further assistance with importing or purchasing Tepezza®?
What is the Generic Name for the trade name drug Adakveo®?
Crizanlizumab-tmca is the Generic Name for the trade name drug Adakveo®.
What is the Manufacturer’s Name of Adakveo®?
Adakveo® is manufactured by Novartis Pharmaceuticals Corporation.
Is Adakveo® approved by the FDA?
Yes, Adakveo® is approved by the FDA. Date of first/initial approval: November 15, 2019.
Where can I get Adakveo® at the best price in India?
To get the best Adakveo® price in India, kindly get in touch with Urgent Meds (a WHO GDP and ISO 9001:2008 certified company). For Adakveo®, a valid medical prescription is required from a treating physician.
What is the dosage and form of Adakveo® supplied?
Adakveo® is supplied in the form of an Injection: 100 mg/10 mL solution in a single-dose vial for IV or intravenous administration.
What are the most common side effects of Adakveo®?
The most common side effects of Adakveo® are nausea, back pain, arthralgia, and pyrexia.
How much does Adakveo® cost in India?
The cost of Adakveo® in India can vary. In order to procure this medication authentically, you can call or WhatsApp +1-647-818-4196 or send mail to info@urgentmeds.in.
What are the storage conditions of Adakveo®?
Store and transport refrigerated at 2-8°C (36-46°F) in the original carton to protect from light. Do not shake or freeze.
Is it safe to buy Adakveo® online in India?
Yes, one can buy Adakveo® in India at the best price from Urgent Meds if Adakveo® is not registered or is unavailable in the respective country. We can facilitate the import of Adakveo® 100 mg injection through legal channels.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.